ArticleCurrent microbiology2025
Evaluation of the Degradation Effect of Zearalenone in feed by Bacillus amyloliquefaciens H6 and its Detoxification in Mice.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isolation and Characterization of Sphingopyxis sp. Q841: A New Zearalenone- Degrading Strain.Current microbiology · 2026Article
- Isolation and characterization of a novel strain of Rhizopus arrhizus for effective biodegradation and detoxification of zearalenone.World journal of microbiology & biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The mycotoxin zearalenone (ZEN), which poses a threat to both human and animal health, is frequently detected in food and feed. Bacillus amyloliquefaciens H6 has been screened and identified as a functional microorganism capable of biodegrading ZEN in the previous studies. The degradation ability of the bacterium towards zearalenone and its derivatives in feed, as well as its protective effect in vivo, remains to be determined. Therefore, degradation tests were conducted on ZEN and its derivatives using bacterial fermentation broth to detoxify moldy feed. Furthermore, protection experiments were performed on mice fed with ZEN using the same fermentation broth. The results demonstrated that the fermentation of Bacillus amyloliquefaciens H6 effectively detoxified moldy feed with an initial concentration of 436.74 μg/kg of ZEN, leading to a significant decrease in its toxin content to 81.53 μg/kg Moreover, it exhibited degradation activity towards ZEN derivatives including α-zearalenol, β-zearalenol and α-zearalanol. Bacillus amyloliquefaciens H6 alleviated the weight loss triggered by ZEN exposure in mice while reversing alterations observed in relative mRNA expression levels associated with serum biochemical markers (ALT, AST, ALP), hepatic oxidative stress indicators (SOD, GSH-Px, CAT, MDA), and Nrf-2 signaling pathway (Nrf-2, HO-1, γ-GCs, GSH-Px). These effects collectively counteract oxidative damage inflicted by ZEN on mouse liver. The Bacillus amyloliquefaciens H6 strain exhibited a mitigating effect on hepatic and small intestinal pathological damage, surpassing the ZEN group in comparison. The cecal anaerobic flora structure was effectively reshaped, leading to significant alterations in microbial composition.
Indexed as
Identifiers
41051534What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.